Novo Nordisk logoNovo Nordisk

Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation

Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation email from Novo Nordisk screenshot

Captured Announcement

Novo Nordisk announces headline results from the ZEUS cardiovascular outcomes phase 3 trial.

Top-aligned corporate logo followed by extensive press release text, contact directory table in two columns, attachment links, and legal footer.

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.